drugset / Trial / NCT06804603
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this study is to measure the effects of using Tradipitant after GLP-1R agonist use on nausea and vomiting in healthy overweight, class I, or class II obese volunteers. The study is placebo-controlled with two treatment arms.
Timeline
- Start
- 2025-02-25
- Primary completion
- 2025-10-06
- Completion
- 2025-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tradipitant | Small molecule | — | Oral |